Operation Everest II: Unraveling the Mysteries of Extreme Altitude Physiology

Operation Everest II (OE II) was a groundbreaking study conducted in October 1985 where 8 subjects and 27 investigators embarked on a simulated 40-day ascent of Mt. Everest at the United States Army Research Institute for Environmental Medicine altitude chambers. Led by Charlie Houston, John Sutton, and Allen Cymerman, the study delved into human responses to extreme altitude, revealing fascinating insights into the body’s adaptations.

The Unique Expedition

OE II was distinctive for its interdisciplinary approach, studying cardiovascular, respiratory, metabolic, muscle, hematological, immunological, and neural responses in the subjects.
The expedition allowed for invasive measurements like systemic arterial and pulmonary arterial catheter placements, providing a level of data collection impossible in field studies.

Cardiovascular Discoveries

Cardiac function remained resilient despite hypoxia, with no impairment observed even at extreme altitudes.
Right ventricular function was preserved, despite pulmonary arterial hypertension, showcasing the body’s remarkable adaptability to high altitudes.

Pulmonary Challenges and Gas Exchange

Pulmonary vascular resistance increased with altitude, but intriguingly decreased during exercise, shedding light on the body’s dynamic responses.
Ventilation-perfusion inequality and diffusion limitation were observed, impacting arterial oxygenation and highlighting the lungs’ struggle at extreme altitudes.

Muscle and Neurological Effects

Muscle atrophy occurred, accounting for significant weight loss, while muscle structure and function remained surprisingly unaffected.
Neuropsychological testing revealed cognitive deficits post-expedition, with higher hypoxic ventilatory responsiveness correlating with greater neuropsychological impairments.

Immune Responses and Metabolic Changes

OE II subjects exhibited immune alterations, with T cell function notably reduced, shedding light on the impact of hypoxic exposure on immune regulation.
Metabolic shifts, including substantial weight loss from fat-free sources and altered lipid profiles, hinted at the body’s complex adjustments to extreme altitude conditions.

Key Takeaways:

OE II provided a comprehensive understanding of human physiological responses to extreme altitude, offering invaluable insights into cardiovascular, respiratory, metabolic, and immune adaptations.
The expedition’s findings paved the way for further research on high-altitude physiology and highlighted the body’s incredible resilience and challenges in oxygen-deprived environments.

Additional Thoughts: “In the quest for understanding the limits of human physiology, Operation Everest II stands as a testament to the relentless pursuit of knowledge in the face of extreme challenges. As we unravel the mysteries of our body’s adaptations to high altitudes, we pave the way for future explorations into the realms of human potential and resilience.”